H

Haleon

Global consumer health care products company

Product and Technology Lead

Full-TimeDeadline 11/4/26
€2.8k - €3.9k+ Annual performance bonus + 13th salary + Commuting allowance + Relocation allowance
Mid
Levice, Slovakia
In PersonOnsite canteen is mentioned; no alternate attendance arrangement is stated.
Manufacturing & Process EngineeringManufacturing Engineering

About the job

Requirements
  • Strong background in product development, process development, manufacturing technology, scale-up or technology transfer.
  • Experience supporting New Product Introduction (NPI) projects within a manufacturing environment.
  • Experience working in FMCG, pharmaceuticals, consumer healthcare, chemicals or a similar highly regulated manufacturing environment.
  • Strong scientific or engineering background.
  • Excellent understanding of manufacturing processes, product development and process optimization.
  • Ability to evaluate technical risks and make data-driven decisions.
  • Experience leading technical investigations and solving complex manufacturing challenges.
  • Hands-on experience in product development, process development, manufacturing technology transfer or scale-up activities is essential.
  • Strong stakeholder management and cross-functional collaboration skills.
  • Ability to influence and work effectively with global and regional teams.
  • Strong analytical thinking and problem-solving capabilities.
  • Strong communication skills in English are essential.
  • Resilience and the ability to thrive in a fast-paced and constantly evolving environment.
  • Strong decision-making skills and attention to detail.
Responsibilities
  • Lead, develop and motivate a team of Product and Process Engineers and Packaging Engineers supporting Product Lifecycle Management activities on site.
  • Serve as the site technical expert and primary point of contact for specific product categories, providing scientific and technical guidance across the product lifecycle.
  • Partner closely with R&D, NPI, Global and Regional teams to successfully transfer innovation projects from development into commercial manufacturing.
  • Support manufacturing operations by providing expert technical guidance and decision-making on product-related challenges, process deviations and technical investigations to ensure product quality, manufacturing continuity and successful product performance.
  • Drive product scale-up activities, ensuring new products and technologies are robustly implemented at site level.
  • Oversee process validation strategies and ensure compliance with regulatory requirements, corporate standards and industry best practices.
  • Lead investigation, deviation and CAPA activities, coaching the team to continuously improve problem-solving effectiveness and technical decision-making.
  • Collaborate with internal and external stakeholders to implement best practices and support audits and regulatory inspections.
  • Use performance management processes, coaching and development planning to build technical capability and strengthen team performance.
Desired Qualifications
  • Previous leadership or people management experience is preferred.
  • Slovak language skills are desirable.

About the company

H

Haleon

View
Website

Haleon is a global consumer health company that develops and sells everyday health products under brands such as Sensodyne, Advil, and Centrum. Its products address oral care, pain relief, immunity, and general well-being, working through science-backed formulations people use daily. Haleon differentiates itself by being a focused, standalone consumer health business formed from GSK’s spin-off and built from leading brands through major acquisitions, operating at scale with a portfolio of category leaders and competing with peers like Kenvue and Procter & Gamble. Its goal is to help people take control of their daily health with trusted products, while expanding its global reach and investing in manufacturing capacity and brand development.

Company Size

10,001+

Company Stage

IPO

Headquarters

Weybridge, United Kingdom

Founded

2022

Get referred to Haleon

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • September 2026 NielsenIQ data showed U.S. share rose to 12.0% from 11.4%.
  • CVS GLP-1 destination shelves delivered a 24% sales lift per store in Q1 2026.
  • H1 2026 organic revenue grew 2.6%, with North America accelerating to 3.1% in Q2.

What critics are saying

  • June 2026 Gas-X recall exposed packaging contamination and bruises trust in core digestive brands.
  • July 2026 decongestant litigation revived claims against Advil Sinus Congestion & Pain in Brooklyn.
  • Heavy promotions covered over 21% of U.S. sales in Q2, risking margin erosion and dependence.

What makes Haleon unique

  • Haleon owns sticky cash brands Sensodyne, Advil, TUMS, Centrum, and Biotène across categories.
  • July 2026 results showed 66.5% gross margin and 24.3% adjusted operating margin.
  • September 2026 retailer resets and CVS GLP-1 shelving show elite U.S. channel execution.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • 401(k) Retirement Plan
  • Paid Parental Leave
  • Flexible Work Hours

Growth & Insights and Company News

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Oct 28th, 2026
Haleon appoints Deep Malde to lead expert marketing and transformation at $42B consumer health group

Haleon (LSE:HLN) has appointed Deep Malde as head of expert marketing and transformation for its consumer health portfolio. Malde previously worked at Mega LifeSciences, Danone, and Abbott Nutrition. His role links brand strategy with engagement of healthcare professionals, who influence purchasing decisions for the over-the-counter products Haleon sells across multiple regions. The company has a market value of about £33.1b. Group organic growth has slowed to 2.6%, and its respiratory health category has softened, which puts pressure on its 4% to 6% growth ambition.

CCentral
Oct 23rd, 2026
Haleon's focus on household convenience.

Haleon's focus on household convenience. Inside 'Health House': Haleon's immersive brand activation in Parkdale, Toronto connects OTC brands to everyday self-care. 10/23/2026 Haleon wants consumers to know that they understand the role convenience stores play in household remedies. That urgent run from the house for that emergency bottle of over-the-counter medicine is especially top of mind during flu season. Bringing household remedy brands under one roof. On October 23, Haleon Canada created Health House, a one-day immersive experience that brought all their brands under one roof. The ordinary-looking house in Parkdale showcased household brands in their natural habitat. The children's bedroom featured Children's Advil and Junior Advil; Adult and children's versions of Buckley's cough syrup were located in the bathroom; Centrum vitamins, VoltaCare and Voltaren were placed in the master bedroom. Bridging the gap between consumer awareness and the Haleon brand. While consumers may be familiar with Haleon's products, they're less familiar with Haleon itself. The brand activation helps store operators and consumers put the popular names to Haleon's brand. "The interactive experience is meant to get us closer to our consumers because we know the importance of hearing from them and understanding their needs," said Sarey Wulf, head of corporate affairs at Haleon Canada "But, we also help the consumer understand a little bit more preventative health and the importance of self-care." Packaging trends: Portability, single-dose options and affordability. Wulf recognizes the growing trend toward travel-size and smaller, single-dose options. "We recognize convenience stores operate in this unique environment. There's limited shelf space, it's a quick grab, something small and compact in a lot of cases. As shopping habits evolve, we're continuing to assess our own packaging formats. I think outside of the convenience store channel, people are looking for smaller pack sizes, broadly speaking, from an affordability perspective as well," reminds Wulf. "It's not only about portability, ease-of-use and convenience, but also there's an affordability component to small pack sizes and we're acutely aware of this as people's lifestyles change and affordability becomes more of a topic for Canadians." Expanding the lineup for cold and flu relief. Haleon's latest product portfolio highlights the August 2026 launch of Buckley's Cough & Mucus Relief Extra Strength (100 ml). Continuing their strong momentum, top-performing 2025 cough, cold and flu (CCF) innovations return to the lineup, including Buckley's Lozenges Extra Strength, Buckley's Nighttime Complete Extra Strength and Buckley's Nighttime Complete Extra Strength Plus Mucus Relief. Beyond core CCF, Haleon is expanding into adjacent categories with three new additions: Advil Migraine & Headache fast-acting liquid gel capsules, VoltaCare Cooling Cream for instant-contact muscle, joint and back pain relief as well as a reformulated Centrum Adult 50+ Complete Multivitamin. Retailer strategy: Securing supply chains and managing seasonal demand. "I think these brands have consistently resonated in the convenience shopper landscape, where people are seeking accessible, quick solutions," adds Wulf. "I'd say more broadly, we're seeing Canadians take a more proactive approach to self-care: Cough and cold season is a really good example of that. People prepare for this season. They know kids are back in school. They know they need to work and continue on with life as symptoms present. We continue to really work closely with our retail partners, including convenience, to just make sure that Canadians can access the products they rely on where they are when they're there." For retailers who know that an uptick in colds and flu means taking care of their inventory and ensuring customers can locate OTC remedies easily. Wulf emphasizes the role inventory plays for the company as well as for the convenience channel. "There's been a number of disruptions globally and it's definitely top of mind for folks. I would say reliable access to everyday health products is our number one priority,"states Wulf. "We are laser-focused on making sure that our customers and consumers can access our products, especially when demand increases, because we know that predictability: Demand increases in the fall." The household setting really "brought home" the point that Canadians are looking for convenience in part of their daily routine. "I think the conversation doesn't end at the house," added Wulf. "It's a two day activation that we hope that people will take with them the need to practice self care." Wulf adds that she hopes the attendees felt empowered by the activation. "I think the convenience retailer plays a really important role in that journey."

exchange4media
Oct 16th, 2026
Deep Malde joins Haleon as Head of Expert Marketing & Transformation.

Deep Malde joins Haleon as Head of Expert Marketing & Transformation. Malde joins Haleon from Mega LifeSciences, where he served as Business Head. Deep Malde has joined Haleon as Head of Expert Marketing & Transformation, bringing experience across consumer healthcare, nutrition, brand strategy and business transformation. Announcing the move on LinkedIn, Malde said he looked forward to nurturing the company's iconic brands to deliver its purpose of providing "better everyday health - with humanity". Malde joins Haleon from Mega LifeSciences, where he served as Business Head from January 2025 to May 2026, overseeing business performance, P&L delivery, sales and marketing teams, and operational efficiency. Before that, he spent over eight years at Danone India in marketing leadership roles, most recently as Head of Marketing - Global Brands Portfolio. Earlier, Malde spent over three years at Abbott Nutrition International, working on the PediaSure portfolio across brand strategy, consumer marketing, healthcare professional engagement and digital activation.

Yahoo Finance
Oct 15th, 2026
Haleon's Excedrin launches nostalgic "My Little Headache" digital pet to promote fast-relief painkiller

Haleon, the consumer health group, has launched Excedrin Rapid Relief, an aspirin-free and caffeine-free pain reliever that uses patented Fast Release Technology. The product is promoted through "My Little Headache," a nostalgic digital pet that shows headache discomfort worsening and how fast relief helps. The campaign shows Haleon testing engagement-led marketing for new products. It follows new marketing leadership and an expanded Microsoft AI collaboration. Analysts see the launch as a confidence boost for brand-building and pricing power rather than a major near-term catalyst. Key risks remain: product quality after recent recalls, and high debt alongside continued dividends and buybacks. Five Simply Wall St Community members put Haleon's fair value between £3.03 and £6.26.

exchange4media
Oct 14th, 2026
Varun Mitra joins Nestlé South Asia as Head of Digital, Data and Analytics - Supply Chain.

Varun Mitra joins Nestlé South Asia as Head of Digital, Data and Analytics - Supply Chain. Before joining Nestlé, Mitra spent nearly six years at Haleon. Varun Mitra has joined Nestlé South Asia as Head of Digital, Data and Analytics - Supply Chain. He announced his new role on LinkedIn. Mitra has experience in digital transformation across consumer goods, retail and consulting. His functional expertise spans marketing, supply chain, manufacturing, sales and human resources. Before joining Nestlé, Mitra spent nearly six years at Haleon, where he most recently served as General Manager, IT, overseeing Commercial, Finance, QSC and Infrastructure. His earlier stints include roles at Accenture, Asian Paints, SAP and Infosys.